Literature DB >> 21627687

A new model for 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR).

J Cederholm1, K Eeg-Olofsson, B Eliasson, B Zethelius, S Gudbjörnsdottir.   

Abstract

AIMS: We assessed the association between risk factors and cardiovascular disease in an observational study of patients with Type 1 diabetes from the Swedish National Diabetes Register.
METHODS: A derivation sample of 3661 patients, aged 30-65 years, 6.1% with previous cardiovascular disease, baseline 2002, and 197 cardiovascular disease events when followed for 5 years until 2007. A separate validation data set of 4484 patients, baseline 2003, 201 cardiovascular disease events when followed for 4 years.
RESULTS: Adjusted hazard ratios at Cox regression for fatal/non-fatal cardiovascular disease were: diabetes duration 2.76 (2.21-3.44); onset age 1.47 (1.21-1.78); log ratio total cholesterol:HDL cholesterol 1.26 (1.09-1.45); log HbA(1c) 1.19 (1.03-1.38); log systolic blood pressure 1.17 (1.01-1.34) (1 SD increase in continuous variables); smoker 1.76 (1.27-2.46); macroalbuminuria (> 200 μg/min) 1.52 (1.10-2.10); previous cardiovascular disease 3.51 (2.54-4.84). All eight variables were used to elaborate a risk equation for 5-year cardiovascular disease risk. Regarding calibration in the derivation data set, ratio predicted 5-year risk (mean 5.4 ± 7.9%) to observed event rate was 1.0. Discrimination was sufficient, with C-statistic 0.83, sensitivity and specificity 72 and 77%, respectively, for the top quartile of predicted risk. Similarly, calibration and discrimination were adequate in the validation data set: ratio of predicted 4-year risk/observed rate 0.94, C-statistic 0.80, sensitivity and specificity 62 and 77%, respectively, for the top quartile.
CONCLUSIONS: This 5-year cardiovascular disease risk model from a large observational study of patients with Type 1 diabetes in routine care showed adequate calibration and discrimination and can be useful for clinical practice. It should also be tested in patients with Type 1 diabetes from other countries.
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21627687     DOI: 10.1111/j.1464-5491.2011.03342.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  21 in total

1.  The role of coronary artery calcification testing in incident coronary artery disease risk prediction in type 1 diabetes.

Authors:  Jingchuan Guo; Sebhat A Erqou; Rachel G Miller; Daniel Edmundowicz; Trevor J Orchard; Tina Costacou
Journal:  Diabetologia       Date:  2018-11-14       Impact factor: 10.122

Review 2.  Cardiovascular disease in type 1 diabetes.

Authors:  Harish Sharma; Mauro Lencioni; Parth Narendran
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

Review 3.  The Evolving Cardiovascular Disease Risk Scores for Persons with Diabetes Mellitus.

Authors:  Yanglu Zhao; Nathan D Wong
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

4.  Simulating lifetime outcomes associated with complications for people with type 1 diabetes.

Authors:  Tom W C Lung; Philip M Clarke; Alison J Hayes; Richard J Stevens; Andrew Farmer
Journal:  Pharmacoeconomics       Date:  2013-06       Impact factor: 4.981

Review 5.  Integrating Biomarkers and Imaging for Cardiovascular Disease Risk Assessment in Diabetes.

Authors:  David M Tehrani; Nathan D Wong
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

6.  Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study.

Authors:  Isabelle Steineck; Jan Cederholm; Björn Eliasson; Araz Rawshani; Katarina Eeg-Olofsson; Ann-Marie Svensson; Björn Zethelius; Tarik Avdic; Mona Landin-Olsson; Johan Jendle; Soffia Gudbjörnsdóttir
Journal:  BMJ       Date:  2015-06-22

7.  Patient-reported outcome measures and risk factors in a quality registry: a basis for more patient-centered diabetes care in Sweden.

Authors:  Sixten Borg; Bo Palaszewski; Ulf-G Gerdtham; Odegaard Fredrik; Pontus Roos; Soffia Gudbjörnsdottir
Journal:  Int J Environ Res Public Health       Date:  2014-11-26       Impact factor: 3.390

8.  Achieving Good Glycemic Control Early After Onset of Diabetes: A Cost-Effectiveness Analysis in Patients with Type 1 Diabetes in Sweden.

Authors:  Johan Jendle; Åsa Ericsson; Barnaby Hunt; William J Valentine; Richard F Pollock
Journal:  Diabetes Ther       Date:  2017-12-04       Impact factor: 2.945

9.  Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study.

Authors:  Elke R Fahrmann; Laura Adkins; Henry K Driscoll
Journal:  Diabetes Care       Date:  2021-07-07       Impact factor: 17.152

10.  24-hour central aortic systolic pressure and 24-hour central pulse pressure are related to diabetic complications in type 1 diabetes - a cross-sectional study.

Authors:  Simone Theilade; Maria Lajer; Tine Willum Hansen; Christel Joergensen; Frederik Persson; Gudbjörg Andrésdottir; Henrik Reinhard; Stine Elkjær Nielsen; Peter Lacy; Bryan Williams; Peter Rossing
Journal:  Cardiovasc Diabetol       Date:  2013-08-27       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.